Sugentech Inc. (KOSDAQ:253840)
 6,570.00
 -10.00 (-0.15%)
  Oct 31, 2025, 3:30 PM KST
Sugentech Revenue
Sugentech had revenue of 3.17B KRW in the quarter ending June 30, 2025, with 103.76% growth. This brings the company's revenue in the last twelve months to 11.64B, up 64.48% year-over-year. In the year 2024, Sugentech had annual revenue of 10.10B with 41.57% growth.
Revenue (ttm) 
 11.64B
Revenue Growth 
 +64.48%
P/S Ratio 
 8.63
Revenue / Employee 
 80.85M
Employees 
 144
Market Cap 
100.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 10.10B | 2.96B | 41.57% | 
| Dec 31, 2023 | 7.13B | -94.27B | -92.97% | 
| Dec 31, 2022 | 101.40B | 24.20B | 31.34% | 
| Dec 31, 2021 | 77.20B | 35.85B | 86.69% | 
| Dec 31, 2020 | 41.35B | 37.51B | 975.45% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Biologics | 5.03T | 
| Celltrion | 3.75T | 
| Yuhan | 2.17T | 
| SK Biopharmaceuticals | 620.28B | 
| PharmaResearch | 449.81B | 
| Sam Chun Dang Pharm. | 215.10B | 
| ALTEOGEN | 158.06B | 
| LigaChem Biosciences | 148.28B |